
|Articles|March 5, 2007
FDA issues draft guidance on CAM products
Advertisement
The FDA is announcing the availability of a draft guidance for industry entitled "Complementary and Alternative Medicine [CAM] Products and Their Regulation by the FDA." The draft guidance discusses when a CAM product is subject to the Federal Food, Drug, and Cosmetic Act or Public Health Service Act. Electronic comments may be submitted by April 30 to
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Rise in Supplement Use Calls for Pharmacist-Led Counseling, Education | NCPA 2025
2
Pneumococcal Diseases Require Constant Vaccine Development | NCPA 2025
3
Why Pharmacists Need to Put More Emphasis on Supplement Education | NCPA 2025
4
How Community Pharmacists Are Proactively Managing Patients’ Migraines | NCPA 2025
5